Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04222959 · ClinicalTrials.gov registry record · NA
An Intervention to Reduce Risk Factors for Adolescent Pregnancy
A NA study of Behavioral Changes, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04222959 is a NA study of Behavioral Changes that has completed, run by San Diego State University. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04222959, a NA study of Behavioral Changes, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will assess the preliminary effects of Girls Invest, an innovative savings intervention that aims to reduce economic, social, and health behavior risks associated with disproportionately high rates of pregnancy among US Latina adolescents. Girls Invest involves a multidisciplinary conceptual model adapting the most effective prevention strategies from the disciplines of public health and economics. Participants receive a savings account (via our collaborating bank) with $100 deposited in increments based on completion of each module of a gender and life skills training via a mobile "app."
Conditions Studied
Interventions
- BEHAVIORAL Girls Invest Intervention
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2023-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04222959
The ClinicalTrials.gov registry entry for NCT04222959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is San Diego State University, which has 118 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Behavioral Changes appearing as the primary indexed condition, and to 1 intervention - of which Girls Invest Intervention is the first listed.
NCT04222959 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04222959 about?
NCT04222959 is a clinical study titled "An Intervention to Reduce Risk Factors for Adolescent Pregnancy". Investigators will assess the preliminary effects of Girls Invest, an innovative savings intervention that aims to reduce economic, social, and health behavior risks associated with disproportionately high rates of pregnancy among US Latina adolescents. Girls Invest involves a multidisciplinary conc...
What is the current status of trial NCT04222959?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2021-12-01. Estimated completion is 2023-12-28.
What conditions does trial NCT04222959 study?
This clinical trial studies the following conditions: Behavioral Changes.
What interventions are being tested in trial NCT04222959?
The interventions under investigation include: Girls Invest Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04222959?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04222959 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.